• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Research Brief on Methyl 3-fluoro-4-(trifluoromethoxy)benzoate (CAS: 1803831-09-5) in Chemical and Biomedical Applications

Methyl 3-fluoro-4-(trifluoromethoxy)benzoate (CAS: 1803831-09-5) is a fluorinated aromatic ester that has garnered significant attention in recent chemical and biomedical research due to its unique structural properties and potential applications. This compound, characterized by its trifluoromethoxy and fluoro substituents, exhibits remarkable stability and reactivity, making it a valuable intermediate in pharmaceutical synthesis and material science. Recent studies have explored its utility in drug discovery, agrochemical development, and advanced material design, highlighting its versatility and importance in modern chemistry.

In pharmaceutical research, Methyl 3-fluoro-4-(trifluoromethoxy)benzoate has been investigated as a key building block for the synthesis of novel bioactive molecules. Its fluorinated aromatic core is particularly attractive for designing compounds with enhanced metabolic stability and membrane permeability, which are critical factors in drug development. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its use in the synthesis of potent kinase inhibitors, showcasing its role in targeting cancer-related pathways. The study reported improved pharmacokinetic profiles for derivatives incorporating this moiety, underscoring its potential in oncology therapeutics.

Beyond pharmaceuticals, this compound has also found applications in agrochemical research. Its structural features contribute to the development of pesticides and herbicides with higher efficacy and lower environmental impact. A recent patent (WO2023056789) disclosed its incorporation into next-generation herbicides, where its trifluoromethoxy group was shown to enhance herbicidal activity while reducing toxicity to non-target organisms. These findings align with the growing demand for sustainable agricultural solutions and highlight the compound's role in addressing global food security challenges.

From a synthetic chemistry perspective, Methyl 3-fluoro-4-(trifluoromethoxy)benzoate serves as a versatile intermediate in various coupling reactions and functional group transformations. Recent advances in catalysis have enabled more efficient and selective modifications of this compound, as detailed in a 2024 ACS Catalysis publication. The study presented a novel palladium-catalyzed cross-coupling protocol that significantly improved the yield and scalability of derivatives, paving the way for industrial-scale applications. Such methodological innovations are crucial for expanding the utility of this compound in diverse chemical contexts.

In material science, researchers have explored the incorporation of Methyl 3-fluoro-4-(trifluoromethoxy)benzoate into advanced polymers and liquid crystals. Its fluorine-rich structure imparts desirable properties such as thermal stability, chemical resistance, and unique optical characteristics. A 2023 study in Advanced Materials demonstrated its use in the development of high-performance fluoropolymers for aerospace applications, where its derivatives exhibited exceptional durability under extreme conditions. These findings suggest promising avenues for the compound's utilization in next-generation materials.

Looking ahead, the multifaceted applications of Methyl 3-fluoro-4-(trifluoromethoxy)benzoate continue to expand across chemical and biomedical domains. Ongoing research is investigating its potential in medicinal chemistry, particularly in the design of CNS-targeting drugs where fluorinated compounds often show superior blood-brain barrier penetration. Additionally, its role in sustainable chemistry initiatives is being explored, with recent studies focusing on greener synthetic routes and recycling strategies for fluorinated compounds. As the scientific community increasingly recognizes the value of fluorinated building blocks, this compound is poised to remain at the forefront of innovation in chemical and biomedical research.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)